ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
-3.49%
Brent Oil
79.395
-0.61%
Bitcoin
69,238.68
-2.16%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sarepta Therapeutics, Inc. (MM) (AVII)

  7. Sarepta Therapeutics, Inc. (MM) (AVII) News

Avi Biopharma (AVII)

Sarepta Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVII
DateTimeSourceHeadlineSymbolCompany
06/05/201508:28Analyst Ratings NetworkSarepta Therapeutics Upgraded to Outperform at Robert W. Baird (AVII)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
12/07/201213:20MarketwiredBooming Biotechnology Industry Continues to Impress Investors in 2012NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
12/07/201211:50MarketwiredAVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective TodayNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
11/07/201211:04Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
06/07/201221:05MarketwiredAVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare ConferenceNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
13/06/201211:03Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
05/06/201221:08Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
01/06/201222:28Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
01/06/201221:30MarketwiredAVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-ComplianceNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
11/05/201214:59MarketwiredPotential Breakout Stock to Watch for 05/11/12: AVVC Issues News ReleaseNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
10/05/201221:14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
10/05/201221:05MarketwiredAVI BioPharma Announces First Quarter 2012 Financial Results and Recent Corporate DevelopmentsNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
10/05/201214:04Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
04/05/201213:20MarketwiredU.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to BenefitNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
04/05/201209:14ZacksZacks #1 Rank Additions for Friday - Tale of the TapeNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
03/05/201213:30MarketwiredAVI BioPharma Announces First Quarter 2012 Financial Results and Corporate Update Conference CallNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
02/05/201209:14ZacksZacks #1 Rank Additions for Wednesday - Tale of the TapeNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
30/04/201221:34Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
25/04/201222:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
25/04/201222:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
25/04/201222:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
25/04/201222:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
25/04/201213:30MarketwiredAVI BioPharma to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystro...NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
20/04/201215:10Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
12/04/201221:33Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
02/04/201214:12Dow Jones NewsUS STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:AVIISarepta Therapeutics, Inc. (MM)
02/04/201213:07Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
02/04/201212:00MarketwiredAVI BioPharma Announces Eteplirsen Meets Primary Endpoint, Demonstrating a Significant Increase in Dystrophin at 24 Weeks Com...NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
31/03/201201:00MarketwiredAVI BioPharma Announces Conference Call and Webcast on Monday, April 2, 2012, to Discuss Top-Line Data Results From the Phase...NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
30/03/201213:30MarketwiredData From AVI BioPharma's Infectious Disease Programs to Be Presented at the 22nd European Congress of Clinical Microbiology ...NASDAQ:AVIISarepta Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:AVII

Your Recent History

LSE
GDR
Genedrive
LSE
EEE
Empire Metals
LSE
PANR
Pantheon Resources
LSE
BP.
Bp
LSE
POS
Plexus
LSE
VAST
Vast Resources
LSE
LLOY
Lloyds Banking
LSE
GGP
Greatland Gold
LSE
EUA
Eurasia Mining
LSE
SRT
Srt Marine Systems
LSE
PFC
Petrofac
LSE
AAZ
Anglo Asian Mining
LSE
TERN
Tern
LSE
I3E
I3 Energy
LSE
BIRD
Blackbird
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved